Oxidant-antioxidant status in Egyptian children with sickle cell anemia: A single center based study

Jornal de Pediatria

Volumn 90, Issue 3, 2014, Pages 286-292

  El Ghamrawy, Mona Kamal ^a   Hanna, Wagdi Maurice ^b   Abdel Salam, Amina ^a   El Sonbaty, Marwa M ^b   Youness, Eman R ^b   Adel, Ahmed ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Antioxidants; Children; Malondialdehyde; Nitrite; Paraoxonase; Sickle cell anemia

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; HEMOGLOBIN; HYDROXYUREA; MALONALDEHYDE; NITRITE; ANTISICKLING AGENT; OXIDIZING AGENT;

ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EGYPT; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; PREDICTIVE VALUE; SICKLE CELL ANEMIA; VITAMIN BLOOD LEVEL; ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD; CASE CONTROL STUDY; METABOLISM; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTIOXIDANTS; ANTISICKLING AGENTS; ARYLDIALKYLPHOSPHATASE; BODY WEIGHT; CASE-CONTROL STUDIES; CHILD; EGYPT; FEMALE; HUMANS; HYDROXYUREA; MALE; MALONDIALDEHYDE; NITRITES; OXIDANTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; VITAMIN E;

EID: 84899943937     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jped.2013.09.005     Document Type: Article

References (31)

1. D. Weatherall, K. Hofman, G. Rodgers, J. Ruffin, and S. Hrynkow A case for developing North-South partnerships for research in sickle cell disease Blood 105 2005 921 923
2. M.H. Steinberg Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches ScientificWorldJournal 8 2008 1295 1324
3. D. Ray, P. Deshmukh, K. Goswami, and N. Garg Antioxidant vitamin levels in sickle cell disorders Natl Med J India 20 2007 11 13
4. K.C. Wood, and D.N. Granger Sickle cell disease: role of reactive oxygen and nitrogen metabolites Clin Exp Pharmacol Physiol 34 2007 926 932
5. K.C. Wood, R.P. Hebbel, and D.N. Granger Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice FASEB J 19 2005 989 991
6. P.P. Landburg, T. Teerlink, B.J. Biemond, D.P. Brandjes, F.A. Muskiet, and A.J. Duits et al. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype Blood Cells Mol Dis 44 2010 229 232
7. C.R. Morris, G.J. Kato, M. Poljakovic, X. Wang, W.C. Blackwelder, and V. Sachdev et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease JAMA 294 2005 81 90
8. D.K. Kaul, X.D. Liu, X. Zhang, L. Ma, C.J. Hsia, and R.L. Nagel Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants Am J Physiol Heart Circ Physiol 291 2006 H167 H175
9. R.B. Francis Jr., and C.S. Johnson Vascular occlusion in sickle cell disease: current concepts and unanswered questions Blood 77 1991 1405 1414
10. A.M. Emokpae, U.P. Ojiefo, and K.G. Aisha Antioxidant enzymes and acute phase proteins correlate with marker of lipid peroxide in adult Nigerian sickle cell disease patients Iran J Basic Med Sci 13 2010 177 182
11. O.G. Arinola, S.A. Olaniyisa, and M.O. Akibinu Evaluation of antioxidant levels and trace elements status in Nigerian sickle cell disease patients with plasmodium parasitae-mia Pak J Nut 7 2008 766 769
12. F. Foluke, A. Kayode, A. Johan, and K. Modupe Total anti-oxidant status in sickle cell disease patients in steady state J Natl Med Assoc 100 2008 891 894
13. R.M. Hasanato Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anemia Ann Saudi Med 26 2006 17 21
14. P.S. Hundekar, A.N. Suryakar, A.C. Karnik, R. Valvi, R.A. Ghone, and S.S. Bhagat The effect of antioxidant supplementation on the oxidant and antioxidant status in sickle cell anemia J Clin Diag Res 5 2011 1339 1342
15. D.S. Darbari, O. Onyekwere, M. Nouraie, C.P. Minniti, L. Luchtman-Jones, and S. Rana et al. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia J Pediatr 160 2012 286 290
16. T.R. Kinney, R.W. Helms, E.E. O'Branski, K. Ohene-Frempong, W. Wang, and C. Daeschner et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial Pediatric Hydroxyurea Group Blood 94 1999 1550 1554
17. M.B. Ruiz-Larrea, A.M. Leal, M. Liza, M. Lacort, and H. de Groot Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes Steroids 59 1994 383 388
18. H. Moshage, B. Kok, J.R. Huizenga, and P.L. Jansen Nitrite and nitrate determinations in plasma: a critical evaluation Clin Chem 41 1995 892 896
19. I. Guevara, J. Iwanejko, A. Dembińska-Kieć, J. Pankiewicz, A. Wanat, and P. Anna et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction Clin Chim Acta 274 1998 177 188
20. A.D. Watson, J.A. Berliner, S.Y. Hama, B.N. La Du, K.F. Faull, and A.M. Fogelman et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein J Clin Invest 96 1995 2882 2891
21. O. Erel A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation Clin Biochem 37 2004 277 285
22. S.K. Jain, S.N. Levine, J. Duett, and B. Hollier Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats Diabetes 40 1991 1241 1244
23. F. YIldIrIm, K. Sermetow, A. Aycicek, A. Kocyigit, and O. Erel Increased oxidative stress in preschool children exposed to passive smoking J Pediatr (Rio J) 87 2011 523 528
24. C.D. Reiter, and M.T. Gladwin An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy Curr Opin Hematol 10 2003 99 107
25. M.H. Steinberg, F. Barton, O. Castro, C.H. Pegelow, S.K. Ballas, and A. Kutlar et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment JAMA 289 2003 1645 1651
26. S.B. King Nitric oxide production from hydroxyurea Free Radic Biol Med 37 2004 737 744
27. V.P. Cokic, R.D. Smith, B.B. Beleslin-Cokic, J.M. Njoroge, J.L. Miller, and M.T. Gladwin et al. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase J Clin Invest 111 2003 231 239
28. P.F. Teixeira Neto, R.P. Gonçalves, D.B. Elias, C.P. de Araújo, and H.I. Magalhães Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil Rev Bras Hematol Hemoter 33 2011 207 210
29. S.L. Primo-Parmo, R.C. Sorenson, J. Teiber, and B.N. La Du The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family Genomics 33 1996 498 507
30. E. Amengual-Cladera, A. Nadal-Casellas, Y. Gómez-Pérez, I. Gomila, R.M. Prieto, and A.M. Proenza et al. Phytotherapy in a rat model of hyperoxaluria: the antioxidant effects of quercetin involve serum paraoxonase 1 activation Exp Biol Med (Maywood) 236 2011 1133 1138
31. J. Kotur-Stevuljevic, S. Spasic, Z. Jelic-Ivanovic, V. Spasojevic-Kalimanovska, A. Stefanovic, and A. Vujovic et al. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients Clin Biochem 41 2008 1067 1073